Researchers conducted the study, which involved 1,090 Pfizer vaccine recipients, to investigate whether people with prior COVID-19 infection have naturally acquired immunity that could be sufficiently enhanced by a single mRNA vaccine dose compared to receiving two doses.
The study also revealed post-vaccination symptoms were more prominent among those with prior infection after the first dose and were similar among both groups after the second dose.
More articles on pharmacy:
FDA downplayed safety risks at Merck plant producing J&J COVID-19 vaccines, whistleblower says
White House knew 2 weeks ago that plant producing J&J vaccine had problems, Politico says
Walgreens reports strong Q2 results thanks to COVID-19 vaccine rollout
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
